Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Okano M – The findings suggest that intranasal glucocorticosteroids might be positioned as first–line drugs for the treatment of both perennial and seasonal allergic rhinitis.

Related Articles

Time Interval and the Factors Associated with the Development of Asthma in Patients with Allergic Rhinitis
Lung, 10/09/09    Relevance Score: 69%

Nonallergic Rhinitis Symptoms More Severe Than Allergic Rhinitis
ScienceDaily, 10/06/09    Relevance Score: 69%

Allergy drug tackles nasal congestion
Reuters, 11/13/09    Relevance Score: 68%

Allergic rhinitis, histamine, and otitis media
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 68%

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 68%

Today in Allergy/Anaphylaxis...keeping you current

Good agreement between parental and self-completed questionnaires about allergic diseases and environmental factors in teenagers
Journal of Clinical Epidemiology, 12/11/09

Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge
Journal of Allergy and Clinical Immunology, 12/10/09

Early-life EBV infection protects against persistent IgE sensitization
Journal of Allergy and Clinical Immunology, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address